In this episode, the TN team discuss three promising vaccine candidates being developed for COVID-19. We take a deep dive into the data from these vaccine trials to try and work out what successes can be celebrated and what unanswered questions still remain.Read more from this podcast: Vaccine 1: Moderna's mRNA-1273Vaccine 2: Oxford University's ChAdOx1Vaccine 3: CanSino Biologics' Adenovirus Type-5Antigen vs Antibody – What Are the Differences?A Vaccine 101Exploring the Drug Development ProcessModerna's COVID-19 Vaccine Shows Positive Interim Results in Phase I Trial
Podden och tillhörande omslagsbild på den här sidan tillhör technologynetworks. Innehållet i podden är skapat av technologynetworks och inte av, eller tillsammans med, Poddtoppen.
